LanZhou Foci Pharmaceutical Co.,Ltd.
Symbool: 002644.SZ
SHZ
7.78
CNYMarktprijs vandaag
68.3675
Koers/Winst Verhouding
-2.3694
Koers/Winst Groei Verhouding
3.97B
MRK Kapitalisatie
- 0.01%
DIV Rendement
LanZhou Foci Pharmaceutical Co.,Ltd. (002644-SZ) Jaarrekeningen
Balans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 1413.19 | 406 | 398.5 | 374.9 | |||||||||||||||||
balance-sheet.row.short-term-investments | -70.42 | -15.8 | 2 | -10.4 | |||||||||||||||||
balance-sheet.row.net-receivables | 2046.86 | 441.8 | 526.5 | 390.8 | |||||||||||||||||
balance-sheet.row.inventory | 1526.12 | 369.7 | 350.4 | 258.8 | |||||||||||||||||
balance-sheet.row.other-current-assets | 74.04 | 21.3 | 15.7 | 10 | |||||||||||||||||
balance-sheet.row.total-current-assets | 5060.22 | 1238.9 | 1291.1 | 1034.6 | |||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 4211.94 | 1061.8 | 1066.8 | 1091.6 | |||||||||||||||||
balance-sheet.row.goodwill | 26.96 | 9 | 4.5 | 4.5 | |||||||||||||||||
balance-sheet.row.intangible-assets | 320.66 | 79.6 | 76.8 | 72 | |||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 347.63 | 88.6 | 81.3 | 76.4 | |||||||||||||||||
balance-sheet.row.long-term-investments | 335.99 | 79.9 | 66.7 | 82.1 | |||||||||||||||||
balance-sheet.row.tax-assets | 205.41 | 53.6 | 52.4 | 51.1 | |||||||||||||||||
balance-sheet.row.other-non-current-assets | 54.24 | 5.3 | 28.4 | 16.2 | |||||||||||||||||
balance-sheet.row.total-non-current-assets | 5155.21 | 1289.2 | 1295.5 | 1317.5 | |||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-assets | 10215.43 | 2528.1 | 2586.6 | 2352.1 | |||||||||||||||||
balance-sheet.row.account-payables | 1338.65 | 310.4 | 311 | 214.3 | |||||||||||||||||
balance-sheet.row.short-term-debt | 98.74 | 24.7 | 13.8 | 14.7 | |||||||||||||||||
balance-sheet.row.tax-payables | 130.95 | 35.1 | 69.4 | 47.6 | |||||||||||||||||
balance-sheet.row.long-term-debt-total | 14.55 | 1.3 | 0.5 | 0.8 | |||||||||||||||||
Deferred Revenue Non Current | 1056.95 | 261 | 278.2 | 295 | |||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 10.03 | - | - | - | |||||||||||||||||
balance-sheet.row.other-current-liab | 19.4 | 5.8 | 110.9 | 4.5 | |||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 1174.53 | 292 | 322.1 | 349.8 | |||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.capital-lease-obligations | 3.23 | 1.3 | 0.5 | 0.8 | |||||||||||||||||
balance-sheet.row.total-liab | 3126.08 | 759.7 | 852.6 | 724.6 | |||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.common-stock | 2042.63 | 510.7 | 510.7 | 510.7 | |||||||||||||||||
balance-sheet.row.retained-earnings | 3119.21 | 776.2 | 746.9 | 654.5 | |||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 1237.35 | 158.4 | 152 | 143.6 | |||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 605.87 | 300.1 | 305.8 | 305.8 | |||||||||||||||||
balance-sheet.row.total-stockholders-equity | 7005.06 | 1745.4 | 1715.4 | 1614.6 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 10215.43 | 2528.1 | 2586.6 | 2352.1 | |||||||||||||||||
balance-sheet.row.minority-interest | 84.28 | 23.1 | 18.6 | 12.9 | |||||||||||||||||
balance-sheet.row.total-equity | 7089.35 | 1768.4 | 1734 | 1627.5 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 10215.43 | - | - | - | |||||||||||||||||
Total Investments | 265.57 | 64.1 | 68.7 | 71.7 | |||||||||||||||||
balance-sheet.row.total-debt | 113.29 | 26 | 14.4 | 15.5 | |||||||||||||||||
balance-sheet.row.net-debt | -1299.9 | -380 | -382.1 | -359.4 |
Kasstroomoverzicht
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 58.12 | 68.1 | 105.9 | 93.5 | |||||||||||||||||
cash-flows.row.depreciation-and-amortization | 3.63 | 52.5 | 49.5 | 48.6 | |||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0.2 | 1 | 0.2 | |||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | -0.2 | -1 | -0.2 | |||||||||||||||||
cash-flows.row.change-in-working-capital | 66.85 | -82.3 | -112.2 | -117 | |||||||||||||||||
cash-flows.row.account-receivables | 59.5 | 59.5 | -210.1 | -66.8 | |||||||||||||||||
cash-flows.row.inventory | -7.3 | -7.3 | -91.7 | -0.8 | |||||||||||||||||
cash-flows.row.account-payables | 0 | -134.7 | 188.6 | -49.5 | |||||||||||||||||
cash-flows.row.other-working-capital | 14.64 | 0.2 | 1 | 0.2 | |||||||||||||||||
cash-flows.row.other-non-cash-items | -71.03 | 27.4 | 29.1 | -13.2 | |||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 57.56 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -8.98 | -22.5 | -41.5 | -32.8 | |||||||||||||||||
cash-flows.row.acquisitions-net | -15.45 | -15.5 | 3.9 | 74.1 | |||||||||||||||||
cash-flows.row.purchases-of-investments | 8.95 | -6 | -2.1 | -3.9 | |||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 7.98 | 8 | -3.9 | 38.1 | |||||||||||||||||
cash-flows.row.other-investing-activites | -15.17 | 1.8 | 0.8 | -32.8 | |||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -22.66 | -34.2 | -42.8 | 42.6 | |||||||||||||||||
cash-flows.row.debt-repayment | -22.59 | -21.5 | -14.2 | -35.3 | |||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.common-stock-repurchased | -0.5 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.dividends-paid | -1.65 | -27.9 | -5.1 | -61.4 | |||||||||||||||||
cash-flows.row.other-financing-activites | -11.1 | -1.3 | 3.9 | 3.3 | |||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -50.87 | -25 | -15.5 | -93.4 | |||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 25.84 | 0.7 | 0.7 | -0.2 | |||||||||||||||||
cash-flows.row.net-change-in-cash | 9.86 | 7.2 | 14.8 | -39.1 | |||||||||||||||||
cash-flows.row.cash-at-end-of-period | 1376.43 | 396.3 | 387.7 | 372.9 | |||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 1366.56 | 389.1 | 372.9 | 412 | |||||||||||||||||
cash-flows.row.operating-cash-flow | 57.56 | 65.7 | 72.4 | 11.9 | |||||||||||||||||
cash-flows.row.capital-expenditure | -8.98 | -22.5 | -41.5 | -32.8 | |||||||||||||||||
cash-flows.row.free-cash-flow | 48.58 | 43.2 | 30.9 | -21 |
Rij winst-en-verliesrekening
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 1130.07 | 1163.1 | 1019.2 | 817.6 | |||||||||||||||||
income-statement-row.row.cost-of-revenue | 765.41 | 801.8 | 733 | 594.5 | |||||||||||||||||
income-statement-row.row.gross-profit | 364.66 | 361.3 | 286.2 | 223.1 | |||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||
income-statement-row.row.research-development | 31.51 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-general-administrative | 17.15 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 154.39 | - | - | - | |||||||||||||||||
income-statement-row.row.other-expenses | -2.01 | -1.6 | -9.7 | 24.4 | |||||||||||||||||
income-statement-row.row.operating-expenses | 262.09 | 262 | 129.4 | 134.6 | |||||||||||||||||
income-statement-row.row.cost-and-expenses | 1027.5 | 1063.8 | 862.3 | 729 | |||||||||||||||||
income-statement-row.row.interest-income | 2.93 | 5.4 | 7.5 | 10.2 | |||||||||||||||||
income-statement-row.row.interest-expense | 0 | 1.2 | 0.7 | 0.9 | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 154.39 | - | - | - | |||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -2.01 | -1.6 | -12.4 | -1.5 | |||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-operating-expenses | -2.01 | -1.6 | -9.7 | 24.4 | |||||||||||||||||
income-statement-row.row.total-operating-expenses | -2.01 | -1.6 | -12.4 | -1.5 | |||||||||||||||||
income-statement-row.row.interest-expense | 0 | 1.2 | 0.7 | 0.9 | |||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 40.06 | 52.5 | 62.2 | 32.2 | |||||||||||||||||
income-statement-row.row.ebitda-caps | 112.68 | - | - | - | |||||||||||||||||
income-statement-row.row.operating-income | 72.62 | 83.3 | 139.4 | 112.4 | |||||||||||||||||
income-statement-row.row.income-before-tax | 70.6 | 81.6 | 127 | 110.8 | |||||||||||||||||
income-statement-row.row.income-tax-expense | 11.28 | 13.5 | 21.1 | 17.3 | |||||||||||||||||
income-statement-row.row.net-income | 58.12 | 67.2 | 108.7 | 93.3 |
Vaak gestelde vragen
Wat is LanZhou Foci Pharmaceutical Co.,Ltd. (002644.SZ) totale activa?
LanZhou Foci Pharmaceutical Co.,Ltd. (002644.SZ) totale activa is 2528102214.000.
Wat is de jaarlijkse omzet van de onderneming?
De jaarlijkse omzet is 576952643.000.
Wat is de winstmarge van de onderneming?
De bedrijfswinstmarge is 0.323.
Wat is vrije kasstroom van de onderneming?
De vrije kasstroom is {free_cash_flow}}.
Wat is de nettowinstmarge van de onderneming?
De nettowinstmarge is 0.051.
Wat is de totale omzet van de onderneming?
De totale opbrengst is 0.064.
Wat is LanZhou Foci Pharmaceutical Co.,Ltd. (002644.SZ) nettowinst (netto-inkomen)?
De nettowinst is 67189706.000.
Wat is de totale schuld van het bedrijf?
De totale schuld is 26031519.000.
Wat zijn de bedrijfskosten?
De bedrijfsuitgaven zijn 261964435.000.
Wat is het kasstroomcijfer van het bedrijf?
Enretprise cash is 365338610.000.